A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix

Gynecologic Oncology

Volumn 76, Issue 1, 2000, Pages 63-66

  Burnett, Alexander F ^a   Roman, Lynda D ^a   Garcia, Agustin A ^a   Muderspach, Laila I ^a   Brader, Kevin R ^a   Morrow, C Paul ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cervical carcinoma; Combination chemotherapy; Deoxycytidine

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; NEUTROPENIA; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT DISEASE; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 0033957908     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5657     Document Type: Article

References (17)

1. Bonomi P, Blessing J A, Stehman F B, DiSaia P J, Walton L, Major F J. Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol. 3:1985;1079.
2. Punkett W, Huang P, Gandhi V. Preclinical characteristics of gemcitabine. Anti-Cancer Drugs. 6:1995;7-13.
3. Bergman A M, Ruiz van Haperer V W, Veerman G, Kuiper C M, Peters G J. Synergistic interaction between cisplatin and gemcitabine in vitro. Clin Cancer Res. 2:1996;521-530.
4. Steward W P. Combination studies with gemcitabine in the treatment of non-small-cell lung cancer. Br J Cancer. 78:1998;15-19.
5. Heinmann V, Wilke H, Possinger K, Mergenthaler K, Clemens M, Konig H J, Illiger H J, Blatter J, Schallhorn A, Fink U. Gemcitabine and cisplatin: combination treatment for advanced and metastatic pancreatic carcinoma. Proc ASCO. 15:1996;A623.
6. Belpomme D, Krakowski I, Beauduin M, Petit T, Canon J L, Janssens J, Ed Pauw A, Moreau V, Kayitalire L. Gemcitabine in combination with cisplatin in stage III or IV ovarian cancer: preliminary phase II results. Proc ASCO. 16:1997;A1300.
7. Stadler W M, Murphy B, Kaufman D, Raghaven D, Voi M. Phase II trial of gemcitabine plus cisplatin in metastatic urothelial cancer. Proc ASCO. 16:1997;A1152.
8. Van Moorsel C J, Veerman G, Vermorken J B, Voorn D A, Kroep J R, Bergman A AM, Pinedo H M, Peters G J. Mechanisms of synergism between gemcitabine and cisplatin. Adv Exp Med Biol. 431:1998;581-585.
9. Goedhals L, Bezwoda W R. A phase II study of gemcitabine in advanced cervix carcinoma: final data. Proc ASCO. 16:1996;A819.
10. Hansen H H. Gemcitabine - a review. Ann Oncol. 7:1996;29.
11. Rosell R, Tonato M, Sandler A. The activity of gemcitabine plus cisplatin in randomized trials in untreated patients with advanced non-small cell lung cancer. Semin Oncol. 25:1998;27-34.
12. Van Moorsel C J, Veerman G, Kuiper C M, Bergman A M, Van der Vijgh W J, Vermorken J B, Peters G J. Mechanism of synergism between gemcitabine and cisplatin in ovarian and non-small cell lung cancer cell lines. Proc ASCO. 37:1996;A2537.
13. Yang L Y, Li L, Liu X M, Keating M J, Plunkett W. Gemcitabine suppresses the repair of cisplatin adducts in plasmid DNA by extracts of cisplatin-resistant human colon carcinoma cells. Proc ASCO. 36:1995;A2124.
14. Omura G A, Blessing J A, Vaccarello L, Berman M L, Clarke-Pearson D L, Mutch D G, Anderson B. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol. 15:1997;165-171.
15. Vokes E E, Leopold K A, Herndon J E, Crawford J, Cooper M R, Clamon G, Epstein J M, Green M R. A CALGB randomized phase II study of gemcitabine or paclitaxel or vinorelbine with cisplatin as induction chemotherapy and concomitant chemoradiotherapy in stage IIIB non-small cell lung cancer: feasibility data. Proc ASCO. 16:1997;A1636.
16. Robertson J M, Shewach D S, Lawrence T S. Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinoma. Cancer. 78:1996;674-679.
17. Eisbruch A, Shewach D S, Urba S, Wolf G T, Bradford C R, Marentette L J, Terrell J E, Hogikyan N D, Esclamado R M, Lawrence T S. Phase I trial of radiation concurrent with low-dose gemcitabine for head and neck cancer: high mucosal and pharyngeal toxicity. Proc ASCO. 16:1997;A1377.